220 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Brivaracetam (Briviact®)

Zorginstituut Nederland has approved a pharmacotherapeutic report for the medicine brivaracetam (Briviact®), whereby they reached ...

Report | 23-05-2016

Lumacaftor/ivacaftor (Orkambi®) by Cystic fibrosis

Based on the GVS criteria, lumacaftor/ivacaftor (Orkambi®) can not be replaced by another drug in the GVS.  The assessment ...

Report | 13-05-2016

Eculizumab (Soliris®) for the treatment of patients with paroxysmal nocturnal haemogloninuria

Zorginstituut Nederland has re-assessed the medicine eculizumab (Soliris®) for the treatment of patients with paroxysmal ...

Report | 13-05-2016

Levo floxacin (Quinsair®) for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa

Zorginstituut Nederland carried out a marginal assessment of the medicine levofloxacin (Quinsair®), whereby they came to the ...

Report | 03-05-2016

Early Intensive Neurorehabilitation of adults with unresponsive wakefulness syndrome or a prolonged minimally conscious state

Report | 29-03-2016

Safinamide (Xadago®) for the treatment of adult patients with idiopathic Parkinson's disease

Zorginstituut Nederland has approved a pharmacotherapeutic report for the medicine safinamide (Xadago®). They reached the ...

Report | 21-03-2016

Onabotulinum toxin A 100 U in cases of idiopathic overactive bladder

Zorginstituut Nederland (the Zorginstituut) concluded that treatment with onabotulin toxin A 100 U does comply with the ...

Report | 25-02-2016

Ivermectin (Soolantra®) by moderate to severe papulopustulous rosacea

Zorginstituut Nederland advises the Minister of Public Health, Welfare and Sport to include ivermectin (Soolantra®) in the GVS on ...

Report | 22-02-2016

Eltrombopag (Revolade®) in cases of severe aplastic anaemia

Zorginstituut Nederland has approved a pharmacotherapeutic report for the medicine eltrombopag (Revolade®) in cases of severe ...

Report | 22-02-2016

Healthcare in the Netherlands

The philosophy underpinning the Dutch healthcare system is based on several more or less universal principles: access to care for ...

Publication | 31-01-2016